JAK2 V617F-Mutated Myeloproliferative Neoplasia Developing Five Years after Wild-Type JAK2 Acute Myeloid Leukemia: A Case Report

Publisher： Karger

E-ISSN： 1421-9662|129|1|23-25

ISSN： 0001-5792

Source： Acta Haematologica, Vol.129, Iss.1, 2012-09, pp. : 23-25

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Wild-Type JAK2 Secondary Acute Erythroleukemia Developing after JAK2-V617F-Mutated Primary Myelofibrosis

By  

Acta Haematologica, Vol. 122, Iss. 1, 2009-08 ,pp. : 36-38

Karger

Access to resources Recommend Favorite

Leukocytosis, JAK2V617F Mutation, and Hemostasis in Myeloproliferative Disorders

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 36, Iss. 3-4, 2009-01 ,pp. : 148-159

Karger

Access to resources Recommend Favorite

Granulocyte whole exome sequencing and endothelial JAK2V617F in patients with JAK2V617F positive Budd‐Chiari Syndrome without myeloproliferative neoplasm

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 3, 2018-02 ,pp. : 443-445

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development of JAK2V617F-Positive Polycythemia Vera after Chemotherapy-Induced Remission of Primary Central Nervous System Diffuse Large B Cell Non-Hodgkin's Lymphoma: A Case Report and Review of the Literature

By  

Acta Haematologica, Vol. 130, Iss. 3, 2013-05 ,pp. : 142-145

Karger

Access to resources Recommend Favorite

Anagrelide Treatment in Early Pregnancy in a Patient with JAK2V617F-Positive Essential Thrombocythemia: Case Report and Literature Review

By  

Acta Haematologica, Vol. 122, Iss. 4, 2009-10 ,pp. : 221-222

Karger

Access to resources Recommend Favorite